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Mutations in TPRN Cause a Progressive Form
of Autosomal-Recessive Nonsyndromic Hearing Loss
Yun Li,1,2,11 Esther Pohl,1,2,11 Redouane Boulouiz,3,11 Margit Schraders,4,5,6 Gudrun Nu¨rnberg,7,8
Majida Charif,3 Ronald J.C. Admiraal,4,6 Simon von Ameln,1,2 Ingelore Baessmann,7 Mostafa Kandil,9
Joris A. Veltman,5,10 Peter Nu¨rnberg,1,7,8 Christian Kubisch,1,2,8 Abdelhamid Barakat,3
Hannie Kremer,4,5,6 and Bernd Wollnik1,2,8,*
We performed genome-wide homozygosity mapping in a large consanguineous family fromMorocco and mapped the autosomal-reces-
sive nonsyndromic hearing loss (ARNSHL) in this family to the DFNB79 locus on chromosome 9q34. By sequencing of 62 positional
candidate genes of the critical region, we identiﬁed a causative homozygous 11 bp deletion, c.42_52del, in the TPRN gene in all seven
affected individuals. The deletion is located in exon 1 and results in a frameshift and premature protein truncation (p.Gly15AlafsX150).
Interestingly, the deleted sequence is part of a repetitive and CG-richmotive predicted to be prone to structural aberrations during cross-
over formation. We identiﬁed another family with progressive ARNSHL linked to this locus, whose affected members were shown to
carry a causative 1 bp deletion (c.1347delG) in exon 1 of TPRN. The function of the encoded protein, taperin, is unknown; yet, partial
homology to the actin-caping protein phostensin suggests a role in actin dynamics.Understanding the various mutational mechanisms and
pathophysiological processes underlying inherited forms
of hearing loss has an important impact on clinical patient
management, genetic counseling, molecular diagnosis,
and development of advanced therapeutic strategies. The
approximate prevalence of hearing loss caused by genetic
factors has been estimated to be at least 1 per 2000,1–3
and the most common hereditary form is autosomal-reces-
sive nonsyndromic hearing loss (ARNSHL), accounting for
> 70% of the cases.1 More than 60 loci for ARNSHL (DFNB)
are known, and, to date, 32 of the corresponding genes
have been identiﬁed (Hereditary Hearing Loss Homepage).
Functional analysis of the encoded proteins provided
intriguing insights into the complex structure of the inner
ear as well as the mechanisms of hearing.4–6
Our strategy for identifying deafness genes is based
mainly on both a collection of large consanguineous fami-
lies with ARNSHL and the use of a homozygosity mapping
approach. All subjects or their legal representatives gave
written informed consent to the study, which was per-
formed in accordance with the Declaration of Helsinki
protocols and approved by the local institutional review
boards. We ascertained 50 ARNSHL families from different
regions of Morocco7 and 39 small ARNSHL families from
The Netherlands. Participating members of all families
underwent general otological examinations and pure-
tone audiometry with air and bone conduction at
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The Ameri8000 Hz (under sound-treated booth conditions). In family
SF40 from Morocco (Figure 1A), all seven affected individ-
uals were born to consanguineous parents and presented
with severe to profound ARNSHL (Figure 1B). In affected
individuals, hearing loss was reported to be congenital,
with a progressive course leading to profound hearing
loss. Developmental milestones were normal, and Rom-
berg test did not reveal any symptoms of vestibular
dysfunction in all patients.
After exclusion of the GJB2 gene (MIM 121011), we gen-
otypedDNAs from available SF40 familymembers by using
the Affymetrix GeneChip Human Mapping 10K SNPArray
(version 2.0). Genotypes were called by the GeneChip
DNA Analysis Software (GDAS v2.0, Affymetrix). We veri-
ﬁed sample genders by counting heterozygous SNPs on
the X chromosome. Relationship errors were evaluated
with the help of the Graphical Relationship Representa-
tion program.8 The PedCheck program was applied to
detect Mendelian errors,9 and data for SNPs with such
errors were removed from the data set. Nonparametric
linkage analysis using all genotypes of a chromosome
was simultaneously carried out with MERLIN. Parametric
linkage analysis was performed by a modiﬁed version of
the GENEHUNTER 2.1 program10,11 through stepwise use
of a sliding window with sets of 110 or 300 SNPs and by
the program ALLEGRO, assuming autosomal-recessive
inheritance with full penetrance and a disease allele
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Figure 1. Mapping of the SF40 Family to the DFNB79 Locus
(A) Haplotype analysis in family SF40 showing homozygous haplotypes of the DFNB79 locus on chromosome 9q34.
(B) Audiograms of pure-tone audiometry with air (blue) and bone (red) conduction of individuals IV-3 (at 24 yrs of age) and IV-4 (at 21 yrs
of age).
(C) Schematic representation of genome-wide LOD score calculations after 10K array SNP genotyping. LOD scores, calculated with
ALLEGRO, are given along the y axis relative to genomic position in cM on the x axis. Note the highest peak in the telomeric region
on chromosome 9q.
(D) Genomic overview of the chromosome 9q34 region and genomic localization of the used microsatellite markers. The black bars
indicate the size and location of the described DFNB79 locus in comparison with the critical regions identiﬁed in the families SF40
and W07-234.We obtained a maximum LOD score of 3.11 for the telo-
meric region on chromosome 9q34.3 (Figure 1C). Subse-
quent ﬁne mapping using microsatellite markers and
including additional family members conﬁrmed shared
homozygosity of a 3.2 Mb region between D9S312 and
the telomere in all affected individuals (Figures 1A and
1D). This region overlaps with the recently described
DFNB79 locus (Figure 1D).12 A two-point LOD score of
4.62 for D9S158was obtained (Table 1), under the assump-
tion of an autosomal-recessive mode of inheritance with
complete penetrance and a disease allele frequency of
0.001, with the use of LINKAGE software (version 5.2).
A total of 88 protein-coding genes were located within
the critical region (UCSC Genome Bioinformatics), and
all genes were analyzed by their expression pattern and
presumed functional properties (OMIM and Unigene).480 The American Journal of Human Genetics 86, 479–484, March 1We sequenced the coding exons and adjacent splice sites
of 62 of these positional candidate genes (Table S1, avail-
able online).
Sequencing of the four exons of the C9orf75 gene
(named TPRN) revealed a homozygous 11 bp deletion in
exon 1, c.42_52del, which cosegregated with the disease
in all affected family members, was heterozygous in the
parents, and was not found in 140 healthy control individ-
uals fromMorocco (Figure 2A). Screening of 35 index cases
of additional Moroccan ARNSHL families did not reveal
any other family carrying this mutation. The c.42_52del
deletion is predicted to cause a frameshift and premature
protein truncation (p.Gly15AlafsX150). Interestingly, the
deletion is part of an 11 bp repetitive and CG-rich motive
(Figure 2A). Also, the neighborhood of the c.42_52del
mutation is very GC rich. It is well known that both2, 2010
Table 1. Two-Point LOD Score Results between the Disease in SF40 and Markers on Chromosome 9qter
Marker Physical Position
Recombination Fraction (q)
0.0 0.01 0.05 0.1 0.2 0.3 0.4
D9S1818 137135350–137135709 0.83 0.81 0.71 0.59 0.36 0.18 0.06
D9S312 137919496–137919616 N 2.48 2.80 2.62 1.97 1.24 0.53
D9S158 139099048–139099430 4.62 4.52 4.08 3.53 2.41 1.31 0.38
D9S1838 140636699–140636978 4.58 4.48 4.09 3.59 2.57 1.54 0.61
Highest LOD scores are shown in bold.(a) repetitive nucleotide stretches and (b) an open chro-
matin structure, which is found in GC-rich regions, can
strongly contribute to the occurrence of structural alter-
ations such as deletions and duplications.13 These repeti-
tive sequences might increase the instability of DNA to
induce either deletions or duplications by the molecular
mechanisms of simple replication slippage, sister-chromo-
some slipped misalignment, and single-strand anneal-
ing.14 Therefore, this part of exon 1 is predicted to be prone
to small structural alterations. Our hypothesis that the
c.42_52del mutationmight represent amutational hotspot
is further supported by the ﬁnding of Rehman et al.,15 who
describe the same c.42_52del mutation in a large ARNSHL
pedigree from Pakistan, as well as another Pakistani family
with a duplication within this repeat, c.44_54 dup. Taken
together, the data from both studies suggest that muta-
tions in TPRN could be a more frequent cause of ARNSHL,
resulting from the mutational mechanisms described
above.
Among the Dutch families, we also identiﬁed a family
with a TPRN mutation. In both affected subjects of family
W07-234 (Figure 2B), results of the Ewing hearing distrac-
tion test at 9 mo of age were normal. Sensorineural hearing
loss was diagnosed at the ages of 4 yrs, 3mo and 2 yrs, 9mo
in patients II-1 and II-2, respectively. At these ages, speech
development was delayed in both individuals. In patient
II-1, the hearing impairment progressed from severe to
profound between age at diagnosis and 26 yrs of age. The
hearing loss in patient II-2 was severe at diagnosis and
profound at the age of 15 (Figure 2B). Individual longitu-
dinal linear regression analysis of binaural mean air-
conduction threshold values on age was performed for
both affected individuals. The annual threshold deteriora-
tion (ATD) was calculated, and the progression was called
signiﬁcant if the 95% conﬁdence interval did not include
zero. The level of signiﬁcance used in all tests was p¼ 0.05.
For individual II-1, the ATD increased from 0.42 at
0.25 kHz to 2.0 at 4 kHz. The progression at 2 kHz (ATD
1.85) was found to be statistically signiﬁcant. For indi-
vidual II-2, the ATD was 1.90, 1.91, 1.76, and 2.70 at
0.5 kHz, 1 kHz, 2 kHz, and 4 kHz, respectively. Progression
was not statistically signiﬁcant for any of these frequen-
cies. The lack of signiﬁcance in progression is likely to be
due to the relatively large variation in the measurementsThe Ameriduring childhood and the low number of measurements.
No additional clinical abnormalities were seen in the
patients in ear, nose, and throat (ENT) and pediatric exam-
inations, and no retinal abnormalities were detected in
funduscopy (individual II-2). GJB2 was initially excluded.
Given the fact that with 16 million inhabitants, the Dutch
population is rather small and that population mixture by
migration and mating could be lower than expected, we
used a homozygosity mapping strategy in Dutch ARNSHL
families without obvious consanguinity. Only affected
individuals from families were analyzed for homozygous
stretches with the use of the Affymetrix GeneChip Human
Mapping 250K NspI SNP Array. Genotype calling and
detection of homozygous regions was performed with
the Genotyping Console software from Affymetrix. In
family W07-234, the largest overlapping homozygous
region, of 9.59 Mb, was located on chromosome
9q22.32-q31.2 (ﬂanking SNPs: SNP_A-2028693, SNP_A-
2061426). The second largest overlapping homozygous
region, of 5.21 Mb, was identiﬁed on chromosome
9q34.13-34.3 (ﬂanking SNPs: SNP_A-1803621, SNP_A-
2186204), which partly overlapped with theDFNB79 locus
(Figure 1D). In total, 11 shared homozygous regions
greater than 1 Mb were identiﬁed for family W07-234.
Independent analysis using microsatellite markers
conﬁrmed the DFNB79-overlapping homozygous stretch
in affected family members (Figure 2B). In both siblings,
we found a 1 bp deletion, c.1347delG, in exon 1 of the
TPRN gene (Figure 2C). The deletion is predicted to cause
a frameshift and a premature protein truncation
(p.Thr450LeufsX32). Parents are heterozygous carriers,
and the mutation was not detected in 160 healthy Dutch
control individuals, tested by PCR and restriction enzyme
digestion using BsmFI (Figure 2C).
Our data provide evidence that loss-of-function muta-
tions in TPRN cause ARNSHL. Interestingly, the hearing
phenotype caused by TPRNmutations shows a progressive
course in the Dutch family described here. Speech acquisi-
tion—although delayed—was possible in the Dutch family
without the use of hearing aids, but hearing impairment
progressed in affected individuals, becoming profound by
young adulthood. Most of the recessively inherited forms
of ARNSHL show a congenital onset and more severe affec-
tion. Progression of ARNSHL has as yet been associatedcan Journal of Human Genetics 86, 479–484, March 12, 2010 481
Figure 2. Identification of Mutations in TPRN in Two ARNSHL Families
(A and C) Sequence chromatograms showing the identiﬁed mutations in the TPRN gene. (A) The homozygous c.42_52del mutation
affects a repetitive motive, as indicated by the boxes. Genotypes of the c.42_52del mutation in 17 family members of the SF40 family
were analyzed by PCR ampliﬁcation and separation on a 4% agarose gel. Fragment sizes are indicated. The upper band represents
a heteroduplex fragment. (B) Haplotypes of microsatellite markers of the DFNB79 region and audiograms of both affected individuals
in the Dutch familyW07-234 at different time points, showing the progression of hearing impairment. (C) Chromatogram of the homo-
zygous c.1347delGmutation identiﬁed in theW07-234 family in comparison with a normal wild-type sequence. The mutation removes
a restriction site for BsmFI. Genotypes of parents and mutation-affected siblings were analyzed with the use of a BsmFI digestion after
PCR ampliﬁcation. Restriction fragments were separated on a 1% agarose gel, resulting in four fragments for the wild-type (361 bp,
317 bp, 229 bp, and 80 bp in size) and three fragments for the homozygous mutant (677 bp, 229 bp, and 80 bp in size).with mutations in only a few other genes, namelyMYO3A
(MIM 606808), TMPRSS3 (MIM 605511), PJVK (MIM
610219), and LOXHD1 (MIM 613072).16–20 TPRN-related
hearing loss represents another example of this character-
istic phenotype.
TPRN isoform 1 encodes a protein 650 amino acids (aa)
in length, named taperin, with yet unknown function.
Different transcripts of the gene are described (Figure 3A).
The expression of the TPRN mouse ortholog
C430004E15Rik (NM_175286.4) was tested in postnatal
day 2 (P2) mice via RT-PCR experiments. We detected
expression of TPRN in all tissues investigated, including
cochlea (Figure 3B). Furthermore, TPRN expression was de-482 The American Journal of Human Genetics 86, 479–484, March 1tected in human fetal cochlea (Figure 3C). In an accompa-
nying paper, Rehman et al. show that taperin is mainly ex-
pressed at the base of inner ear stereocilia in a region
referred to as the taper.15 Future investigations of expres-
sion proﬁles of TPRN in different stages of inner ear devel-
opment will determine the spatiotemporal expression in
the cochlea and the central auditory pathway. Homology
searches identiﬁed a 58 aa stretch of taperin (482–539 aa)
with a 76% similarity to phostensin, a protein involved
in actin dynamics through capping to pointed ends of
actin ﬁlaments.21 Whether taperin has a similar functional
role in actin dynamics remains to be elucidated in the
future.2, 2010
Figure 3. TPRN Structure and Expression
(A) Schematic representation of described
TPRN transcripts (NM_001128228.1,
NM_173691.3), encoded amino acids of
the TPRN protein (NP_775962.2,
NP_001121700.1), and location of identi-
ﬁed mutations.
(B and C) Analysis of TPRN expression by
RT-PCR in different tissues in P2 mouse
and human fetal cochlea (gDNA, genomic
DNA; C, water control). PCR primers for
mouse RT-PCR were located in exon 1
(forward, 50-TCTGACACAGACAAGTGTG
TTAGG-30) and exon 2 (reverse, 50-CAGAG
AGCTCTCAGAAGGGTACTC-30) of TPRN.
Primers for RT-PCR on human fetal
cochlea were located in exon 3 (forward,
50-CTCAGGCCTGTCCAGCTAC-30) and
exon 4 (reverse, 50-AGTGCTGGGCTCA
GAAATAC-30).In conclusion, we provide evidence that mutations in
TPRN cause ARNSHL charcterized by a progressive course
of hearing impairment. The identiﬁed c.42_52del deletion
is a recurrent mutation possibly originating by recombina-
tion errors due to a GC-rich and repetitive nature of this
region. Future screening of additional ARNSHL families
of different origins will provide important information
about the frequency of TPRN mutations.Supplemental Data
Supplemental Data include one table and can be found with this
article online at http://www.ajhg.org.Acknowledgments
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